American National Bank Regeneron Pharmaceuticals, Inc. Transaction History

American National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	SELL	$705.89 - $766.39 $2,117 - $2,299	-3 Reduced 23.08%	10 $7,000
Q3 2022 Oct 05, 2022	SELL	$573.97 - $724.32 $16,071 - $20,280	-28 Reduced 68.29%	13 $9,000
Q2 2022 Jul 11, 2022	BUY	$548.35 - $738.84 $16,998 - $22,904	31 Added 310.0%	41 $24,000
Q1 2022 Apr 08, 2022	BUY	$595.12 - $698.43 $5,951 - $6,984	10 New	10 $7,000
Q2 2021 Jul 12, 2021	SELL	$472.8 - $558.54 $4,728 - $5,585	-10 Closed	0 $0
Q1 2021 Apr 09, 2021	BUY	$446.73 - $548.2 $4,467 - $5,482	10 New	10 $5,000

1,484

83.7M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of American National Bank, based on Form 13F filings with the SEC.

Stay updated on American National Bank with notifications on news.